Researcher

    Frank Rauch , M.D.

    frauch@shriners.mcgill.ca
    Frank Rauch
    Research Axis
    Musculoskeletal Diseases and Rehabilitation
    Research Theme
    Spinal deformities and musculoskeletal diseases
    Address
    CHUSJ - Centre de Recherche

    Phone
    514 345-4931 #8602

    Fax
    514 842-5581

    Title

    • Director, Biomedical Laboratory, Shriners Hospital for Children, Montreal.
    • Pediatrician, Shriners Hospital for Children, Montreal.
    • Associate Professor, Department of Pediatrics, Faculty of Medicine, McGill University.

    Education

    • Postdoctoral Fellowship in Molecular Bone Biology and Bone Histomorphometry, Shriners Hospital for Children, Montreal, 1997-1999.
    • Residency in Pediatrics, Children's Hospital, University of Cologne, Germany, 1992-1997.
    • MD, Munich Technical University, Germany, 1991.

    Research Interests

    • Pediatric osteoporosis;
    • Muscle-bone interaction in children;
    • Bone dysplasias;
    • Bone histomorphometry.

    Awards and Distinctions

    • Editor-in-Chief, Journal of Neuronal and Musculoskeletal Interactions, 2009.
    • Junior 2 Clinical Research Scholar, Fonds de la recherche en santé du Québec, 2008.
    • Hufeland Award, German Health Insurance (preventive medicine), 2003.

    Presentations

    • Skeletal development in children: Beyond getting longer, denser, heavier. 8th Joint Meeting of the Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology, New York, USA, September 12, 2009.
    • The muscle-bone unit in osteogenesis imperfecta type I. 5th Black Forest Forum for Musculoskeletal Interactions, Bad Liebenzell, Allemagne, May 30, 2009.
    • Management of osteogenesis imperfecta. 2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone & Mineral Society, Sydney, Australia, March 24, 2009.
    • Bisphosphonate therapy in fibrous dysplasia. 5th Annual International Pediatric Orthopaedic Symposium, Orlando, USA, December 3, 2008.
    • Vibration therapy. Workshop on adults with cerebral palsy of the 62nd Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine, Atlanta, USA, September 15, 2008.
    • Regulation of bone strength in children. 30th Annual Meeting of the American Society for Bone and Mineral Research, Montreal, September 12, 2008.

Publications

Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome - Phan V, Blydt-Hansen TD, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R, Cummings E, Filler G, Grant R, Grimmer J, Hébert D, Lentle B, Ma J, Matzinger M, Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch F, Siminoski K, Ward LM, Canadian STOPP Consortium. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome
. Osteoporosis Int 2014; 25(2): 627-637.

Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients - Rauch F, Moffatt P, Cheung M, Roughley P, Lalic L, Lund AM, Ramirez N, Fahiminiya S, Majewski J, Glorieux FH. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients. J Med Genet 2013; 50(1): 21-24.

Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2 - Moffatt P, Ben Amor M, Glorieux FH, Roschger P, Klaushofer K, Schwartzentruber JA, Paterson A, Hu P, Marshall C, FORGE Canada Consortium, Fahiminiya S, Majewski J, Beaulieu C, Boycott KM, Rauch F. Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2. Am J Hum Genet 2013; 92(2): 252-258.

Mutations in WNT1 are a cause of osteogenesis imperfecta - Fahiminiya S, Majewski J, Mort JS, Moffatt P, Glorieux FH, Rauch F. Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet 2013; 50(5): 345-348.

Analysing gait using a force-measuring walkway: intrasession repeatability in healthy children and adolescents - Veilleux LN, Ballaz L, Robert M, Lemay M, Rauch F. Analysing gait using a force-measuring walkway: intrasession repeatability in healthy children and adolescents. Comp Meth Biomech Biomed Eng 2013; (sous presse).

Cortical and trabecular bone density in X-linked hypophosphatemic rickets - Cheung M, Roschger P, Klaushofer K, Veilleux LN, Roughley P, Glorieux FH, Rauch F. Cortical and trabecular bone density in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 2013; 98(5): E954-E961.

The muscle-bone relationship in X-linked hypophosphatemic rickets - Veilleux LN, Cheung M, Glorieux FH, Rauch F. The muscle-bone relationship in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 2013; 98(5): E990-995.

Vitamin D status in montreal preschoolers is satisfactory despite low vitamin D intake - El Hayek J, Pham TT, Finch S, Hazell TJ, Jean-Philippe S, Vanstone CA, Agellon S, Rodd C, Rauch F, Weiler H. Vitamin D status in montreal preschoolers is satisfactory despite low vitamin D intake. J Nutr 2013; 143(2): 154-160.

Bone mineral density measured by a portable X-ray device agrees with dual-energy X-ray absorptiometry at forearm in preschool aged children - Hazell TJ, Vanstone CA, Rodd C, Rauch F, Weiler H. Bone mineral density measured by a portable X-ray device agrees with dual-energy X-ray absorptiometry at forearm in preschool aged children. J Clin Densitom 2013; 16(3): 302-307.

Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases - Shiff N, Brant R, Guzman J, Cabral DA, Huber AM, Miettunen P, Roth J, Scuccimarri R, Alos N, Atkinson S, Collet JP, Couch R, Cummings E, Dent P, Ellsworth J, Hay J, Houghton K, Jurencak R, Lang B, Larché M, LeBlanc C, Rodd C, Saint-Cyr C, Stein R, Stephure D, Taback S, Rauch F, Ward LM, Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases. Arthritis Care Res (Hoboken) 2013; 65(1): 113-121.

Evaluation of the severity of malocclusions in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy indexes - Rizkallah J, Schwartz S, Rauch F, Glorieux F, Vu DD, Muller K, Retrouvey JM. Evaluation of the severity of malocclusions in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy indexes. Am J Orthod Dentofacial Orthop 2013; 143(3): 336-341.

The development of bone mineral lateralization in the arms - Siminoski K, Lee KC, Abish S, Alos N, Bell L, Blydt-Hansen TD, Couch R, Cummings E, Ellsworth J, Feber J, Fernandez C, Halton J, Huber AM, Israels S, Jurencak R, Lang B, Laverdière C, LeBlanc C, Lewis V, Midgley J, Miettunen P, Oen K, Phan V, Pinsk M, Rauch F, Rodd C, Roth J, Saint-Cyr C, Scuccimarri R, Stephure D, Taback S, Wilson B, Ward LM, the Canadian STOPP Consortium (National Pediatric Bone Health Working Group). The development of bone mineral lateralization in the arms. Osteoporosis Int 2013; 24(3): 999-1006.

Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI - Rauch F, Husseini A, Roughley P, Glorieux FH, Moffatt P. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab 2012; 97(8): E1550-1556.

The dynamics of bone structure development during pubertal growth - Rauch F. The dynamics of bone structure development during pubertal growth. J Musculoskelet Neuronal Interact 2012; 12(1): 1-6.

Serum 24,25-dihydroxyvitamin d concentrations in osteogenesis imperfecta: relationship to bone parameters - Edouard T, Husseini A, Glorieux FH, Rauch F. Serum 24,25-dihydroxyvitamin d concentrations in osteogenesis imperfecta: relationship to bone parameters. J Clin Endocrinol Metab 2012; 97(4): 1243-1249.

The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy - Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger M, Ward LM. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporosis Int 2012; 23(11): 2703-2711.

Low bone mass and high material bone density in two patients with Loeys-Dietz syndrome caused by transforming growth factor receptor 2 mutations - Ben Amor IM, Edouard T, Glorieux FH, Chabot G, Tischkowitz M, Roschger P, Klaushofer K, Rauch F. Low bone mass and high material bone density in two patients with Loeys-Dietz syndrome caused by transforming growth factor receptor 2 mutations. J Bone Miner Res 2012; 27(3): 713-718.

Agreement between vertical ground reaction force and ground reaction force vector in five common clinical tests - Veilleux LN, Rauch F, Lemay M, Ballaz L. Agreement between vertical ground reaction force and ground reaction force vector in five common clinical tests. J Musculoskelet Neuronal Interact 2012; 12(4): 219-223.

A co-occurrence of osteogenesis imperfecta type VI and cystinosis - Tucker T, Nelson T, Sirrs S, Roughley P, Glorieux FH, Moffatt P, Schlade-Bartusiak K, Brown L, Rauch F. A co-occurrence of osteogenesis imperfecta type VI and cystinosis. Am J Med Genet A 2012; 158A(6): 1422-1426.

Abnormalities in muscle density and muscle function in hypophosphatemic rickets - Veilleux LN, Cheung M, Ben Amor M, Rauch F. Abnormalities in muscle density and muscle function in hypophosphatemic rickets. J Clin Endocrinol Metab 2012; 97(8): E1492-1498.

Muscle force and power in obese and overweight children - Rauch R, Veilleux LN, Rauch F, Bock D, Welisch E, Filler G, Robinson T, Burrill E, Norozi K. Muscle force and power in obese and overweight children. J Musculoskelet Neuronal Interact 2012; 12(2): 80-83.

High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy - Alos N, Grant R, Ramsay T, Halton J, Cummings E, Miettunen P, Abish S, Atkinson S, Barr R, Cabral DA, Cairney E, Couch R, Dix D, Fernandes CV, Hay J, Israels S, Laverdière C, Lentle B, Lewis V, Matzinger M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Wilson B, Williams K, Rauch F, Siminoski K, Ward LM. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 2012; 30(22): 2760-2767.

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome - Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen TD, Clarson C, Filler G, Hay J, Hébert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM, Laverdière C, Canadian STOPP Consortium. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporosis Int 2012; 23(2): 751-760.

Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study - Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, Miettunen P, Roth J, Atkinson S, Couch R, Cummings E, Dent P, Ellsworth J, Hay J, Houghton K, Jurencak R, Larché M, LeBlanc C, Oen K, Saint-Cyr C, Stein R, Stephure DK, Taback S, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM, Laverdière C, Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 2012; 64(1): 122-131.

Muscle-bone characteristics in children with Prader-Willi syndrome - Edouard T, Deal C, Van Vliet G, Gaulin N, Moreau A, Rauch F, Alos N. Muscle-bone characteristics in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2012; 97(2): E275-281.

Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with Calcitriol - Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with Calcitriol. J Clin Endocrinol Metab 2011; 96(1): 82-89.

Cranial base abnormalities in osteogenesis imperfecta: Phenotypic and genotypic determinants - Cheung M, Arponen H, Roughley P, Azouz ME, Glorieux FH, Waltimo-Sirén J, Rauch F. Cranial base abnormalities in osteogenesis imperfecta: Phenotypic and genotypic determinants. J Bone Miner Res 2011; 26(2): 405-413.

Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism Ib: bone histomorphometric analysis - Sbrocchi AM, Rauch F, Lawson M, Hadjiyannakis S, Lawrence S, Bastepe M, Juppner H, Ward LM. Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism Ib: bone histomorphometric analysis. Eur J Endocrinol 2011; 164(2): 295-301.

Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome - Sbrocchi AM, Rauch F, Matzinger M, Feber J, Ward LM. Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome. Pediatr Nephrol 2011; 26(1): 139-142.

Relationship between vitamin D status and bone mineralization, mass and metabolism in children with Osteogenesis imperfecta: histomorphometric study - Edouard T, Glorieux FH, Rauch F. Relationship between vitamin D status and bone mineralization, mass and metabolism in children with Osteogenesis imperfecta: histomorphometric study. J Bone Miner Res 2011; 26(9): 2245-2251.

Gait analysis using a force-measuring gangway: Intrasession repeatability in healthy adults - Veilleux LN, Robert M, Ballaz L, Lemay M, Rauch F. Gait analysis using a force-measuring gangway: Intrasession repeatability in healthy adults. J Musculoskelet Neuronal Interact 2011; 11(1): 27-33.

Mutations in SERPINF1 cause osteogenesis imperfecta type VI - Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 2011; 26(12): 2798-2803.

Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta - Edouard T, Glorieux FH, Rauch F. Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab 2011; 96(10): 3193-3198.

Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta - Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos 2011; 2011: 540178.

Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP - Amor IM, Rauch F, Gruenwald K, Weis M, Eyre DR, Roughley P, Glorieux FH, Morello R. Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP. Am J Med Genet A 2011; 155A(11): 2865-2870.

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study - Ward LM, Rauch F, Whyte MP, D'Astous J, Gates PE, Grogan D, Lester EL, McCall RE, Pressly TA, Sanders JO, Smith PA, Steiner RD, Sullivan E, Tyerman G, Smith-Wright DL, Verbruggen N, Heyden N, Lombardi A, Glorieux FH. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 2011; 96(2): 355-364.

Activities and participation in young adults with osteogenesis imperfecta - Montpetit K, Dahan-Oliel N, Ruck-Gibis J, Fassier F, Rauch F, Glorieux F. Activities and participation in young adults with osteogenesis imperfecta. J Pediatr Rehabil Med 2011; 4(1): 13-22.

Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year - Ruck J, Dahan-Oliel N, Montpetit K, Rauch F, Fassier F. Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop 2011; 5(3): 217-224.

Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8 - Kaneko H, Kitoh H, Matsuura T, Masuda A, Itoh M, Mottes M, Rauch F, Ishiguro N, Ohno K. Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8. Hum Genet 2011; 130(5): 671-683.

Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta - Rauch F, Lalic L, Roughley P, Glorieux FH. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 2010; 25(6): 1367-1374.

Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model - Rauch F, Schwabe K, Krauss JK. Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model. Behav Brain Res 2010; 210(1): 46-53.

What is new in neuro-musculoskeletal interactions: from medical myths to YouTube - Rauch F. What is new in neuro-musculoskeletal interactions: from medical myths to YouTube. J Musculoskelet Neuronal Interact 2010; 10(3): 191-192.

Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions - Rauch F, Sievanen H, Boonen S, Cardinale M, Degens H, Felsenberg D, Roth J, Schoenau E, Verschueren S, Rittweger J. Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions. J Musculoskelet Neuronal Interact 2010; 10(3): 193-198.

Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I - Rauch F, Lalic L, Roughley P, Glorieux FH. Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet 2010; 18(6): 642-647.

Wormian bones in osteogenesis imperfecta: Correlation to clinical findings and genotype - Semler O, Cheung M, Glorieux FH, Rauch F. Wormian bones in osteogenesis imperfecta: Correlation to clinical findings and genotype. Am J Hum Genet 2010; 152A(7): 1681-1687.

Role of cartilage-associated protein in skeletal development - Morello R, Rauch F. Role of cartilage-associated protein in skeletal development. Curr Osteoporos Rep 2010; 8(2): 77-83.

Reproducibility of jumping mechanography in healthy children and adults - Veilleux LN, Rauch F. Reproducibility of jumping mechanography in healthy children and adults. J Musculoskelet Neuronal Interact 2010; 10(4): 256-166.

Postnatal vitamin D supplementation following maternal dietary vitamin D deficiency does not affect bone mass in weanling guinea pigs - Finch SL, Rauch F, Weiler H. Postnatal vitamin D supplementation following maternal dietary vitamin D deficiency does not affect bone mass in weanling guinea pigs. J Nutr 2010; 140(9): 1574-1581.

Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease - Ward LM, Rauch F, Matzinger M, Benchimol Y, Boland M, Mack D. Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporosis Int 2010; 21(2): 331-337.

CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII - Fratzl-Zelman N, Morello R, Lee B, Rauch F, Glorieux FH, Misof BM, Klaushofer K, Roschger P. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone 2010; 46(3): 820-826.

Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders - Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure DK, Taback S, Dent P, Ellsworth J, LeBlanc C, Saint-Cyr C, Scuccimarri R, Hay J, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM, Alos N, Laverdière C, Phan V, Dubois J, Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 2010; 62(4): 516-526.

Higher BMC and areal BMD in children and grandchildren of individuals with hip or knee replacement - Specker BL, Wey HE, Binkley TL, Beare TM, Smith EP, Rauch F. Higher BMC and areal BMD in children and grandchildren of individuals with hip or knee replacement. Bone 2010; 46(4): 1000-1005.

Vibration treatment in cerebral palsy: A randomized controlled pilot study - Ruck J, Chabot G, Rauch F. Vibration treatment in cerebral palsy: A randomized controlled pilot study. J Musculoskelet Neuronal Interact 2010; 10(1): 77-83.

Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study - Rauch F, Munns C, Land C, Cheung M, Glorieux FH. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res 2009; 24(7): 1282-1289.

Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions - Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 2008; 11(1): 22-28.

Intracortical remodeling during human bone development--a histomorphometric study - Rauch F, Travers R, Glorieux FH. Intracortical remodeling during human bone development--a histomorphometric study. Bone 2007; 40(2): 274-280.

Effect of a single botulinum toxin injection on bone development in growing rabbits - Rauch F, Hamdy R. Effect of a single botulinum toxin injection on bone development in growing rabbits. J Musculoskelet Neuronal Interact 2006; 6(3): 264-268.

Osteogenesis imperfecta - Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004; 363(9418): 1377-1385.

About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine